Thông tin thuốc gốc
Chỉ định và Liều dùng
Adult: Initially, 10 mg as a single dose or 5 mg bid, may be increased if necessary, to a Max of 20 mg daily.

CHF (congestive heart failure), Hypertension
Adult: As adjunct to thiazide or loop diuretics to conserve K: Initially, 2.5 mg daily, may increase gradually to a Max of 10 mg daily.

Hepatic cirrhosis with ascites and oedema
Adult: As adjunct to thiazide or loop diuretics to conserve K: Initially, 5 mg daily, may increase gradually to a Max of 10 mg daily.
Suy thận
Severe: Contraindicated.
Cách dùng
Should be taken with food.
Chống chỉ định
Hyperkalaemia (serum K levels >5.5 mEq/L), anuria, diabetic nephropathy, Addison’s disease, acute or chronic renal insufficiency. Concomitant use with other K-conserving agents (e.g. spironolactone, triamterene), K supplements, K-containing salt substitutes, or K-rich diet.
Thận trọng
Patient with diabetes mellitus, adrenal insufficiency, risk factors for metabolic or respiratory acidosis (e.g. poorly controlled diabetes, cardiopulmonary disease). Hepatic impairment. Elderly. Pregnancy and lactation.
Tác dụng không mong muốn
Significant: Electrolyte imbalance (e.g. hyponatraemia, hypochloraemia); increased BUN, serum creatinine; metabolic or respiratory acidosis; hepatic encephalopathy (with severe liver impairment).
Blood and lymphatic system disorders: Aplastic anaemia, neutropenia.
Cardiac disorders: Angina pectoris, palpitation, chest pain.
Ear and labyrinth disorders: Tinnitus.
Eye disorders: Minor visual disturbances, increased IOP.
Gastrointestinal disorders: Nausea, vomiting, diarrhoea, constipation, abdominal pain, dyspepsia, flatulence, heartburn, thirst, dry mouth, gastrointestinal bleeding.
General disorders and administration site conditions: Weakness, fatigue, malaise.
Hepatobiliary disorders: Jaundice.
Investigations: Increased serum uric acid, abnormal LFT(s).
Metabolism and nutrition disorders: Anorexia, dehydration.
Musculoskeletal and connective tissue disorders: Muscle cramps, joint pain, back pain, neck or shoulder pain, pain in extremities.
Nervous system disorders: Headache, dizziness, paraesthesia, tremor, vertigo.
Psychiatric disorders: Nervousness, agitation, mental confusion, insomnia, somnolence, depression, minor psychiatric changes.
Renal and urinary disorders: Urinary disturbances (e.g. polyuria, dysuria, bladder spasms, urinary frequency).
Reproductive system and breast disorders: Sexual dysfunction, impotence.
Respiratory, thoracic and mediastinal disorders: Cough, dyspnoea, nasal congestion.
Skin and subcutaneous tissue disorders: Mild skin rashes, pruritus, alopecia.
Vascular disorders: Orthostatic hypotension.
Potentially Fatal: Hyperkalaemia and increased risk of cardiac arrhythmias.
Chỉ số theo dõi
Monitor serum electrolyte (especially K), blood pressure, renal function, fluid status, and ECG abnormalities (if hyperkalaemia occurred). Assess for signs and symptoms of hyperkalaemia.
Quá liều
Symptoms: Dehydration and electrolyte imbalance. Management: Symptomatic and supportive treatment. May induce emesis or perform gastric lavage. If severe hyperkalaemia occurs, may administer IV Na bicarbonate, or oral or parenteral administration of glucose with a rapid-acting insulin preparation to decrease serum K levels. May also consider administration of Na polystyrene sulfonate given orally or via enema. Patients with persistent hyperkalaemia may require dialysis.
Tương tác
Increased risk of hyperkalaemia with other K-sparing diuretics (e.g. spironolactone, triamterene), K supplements, ARBs, ACE inhibitors, ciclosporin, tacrolimus, aliskiren, trimethoprim, pentamidine, drospirenone, trilostane, and indometacin. Hyponatraemia and hypochloraemia may occur with other diuretics. May reduce the renal clearance of lithium, hence may increase the risk of toxicity. May reduce the inotropic effect of digoxin. Increased risk of hyponatraemia with carbamazepine, and chlorpropamide. Increased risk of nephrotoxicity and ototoxicity with platinum compounds. Antagonised diuretic effect with NSAIDs (e.g. ketorolac), corticosteroids, and estrogens. Enhanced hypotensive effect with diazoxide, aldesleukin, alprostadil, baclofen, tizanidine, levodopa, co-beneldopa, co-careldopa, anaesthetics, anxiolytics/hypnotics, and other antihypertensives. Increased risk of postural hypotension with TCAs or MAOIs. May reduce the ulcer healing properties of carbenoxolone.
Tương tác với thức ăn
Food reduces the extent of absorption or bioavailability. Increased risk of hyperkalaemia with K-rich diet. Enhanced hypotensive effects with alcohol.
Tác dụng
Mechanism of Action: Amiloride is a K-sparing diuretic that has weak natriuretic, diuretic, and antihypertensive activity It blocks the epithelial Na channels in the late distal convoluted tubules (DCT) and collecting duct, leading to the inhibition of Na reabsorption from the lumen which efficiently decreases intracellular Na and reduces Na+/K+-ATPase function resulting in K retention and diminished excretion of Ca, Mg, and hydrogen.
Onset: Within 2 hours.
Duration: Approx 24 hours.
Absorption: Incompletely absorbed from the gastrointestinal tract. Food reduces the extent of absorption and bioavailability. Bioavailability: Approx 50%. Time to peak plasma concentration: 3-4 hours.
Distribution: Volume of distribution: 350-380 L.
Excretion: Via urine (50% as unchanged drug); faeces (approx 40%). Elimination half-life: 6-9 hours. Terminal half-life: Approx ≥20 hours.
Đặc tính

Chemical Structure Image

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 16231, Amiloride. Accessed Dec. 20, 2023.

Bảo quản
Store between 20-25°C.
Phân loại MIMS
Thuốc lợi tiểu
Phân loại ATC
C03DB01 - amiloride ; Belongs to the class of other potassium-sparing agents. Used as diuretics.
Tài liệu tham khảo
Amiloride 5 mg/5 mL Oral Solutions (Essential Pharma Limited). MHRA. Accessed 19/09/2023.

Amiloride Hydrochloride 5 mg Tablets (Genethics Europe Limited). MHRA. Accessed 19/09/2023.

Amiloride Hydrochloride Tablet (Sigmapharm Laboratories, LLC). DailyMed. Source: U.S. National Library of Medicine. Accessed 19/09/2023.

Anon. Amiloride Hydrochloride. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. Accessed 19/09/2023.

Anon. Amiloride. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. Accessed 19/09/2023.

Buckingham R (ed). Amiloride Hydrochloride. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. Accessed 19/09/2023.

Joint Formulary Committee. Amiloride Hydrochloride. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. Accessed 19/09/2023.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Amiloride từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2024 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in